Multicenter prevalence study comparing molecular and toxin assays for clostridioides difficile surveillance, Switzerland

Widmer, A.F.; Frei, R.; Kuijper, E.J.; Wilcox, M.H.; Schindler, R.; Spaniol, V.; ... ; Tschudin-Sutter, S. (2020)

Article / Letter to editor

Public health authorities in the United States and Europe recommend surveillance for Clostridioides difficile infections among hospitalized patients, but differing diagnostic algorithms can hamper comparisons between institutions and countries. We compared surveillance based on detection of C. difficile by PCR or enzyme immunoassay (EIA) in a nationwide C. difficile prevalence study in Switzerland. We included all routinely collected stool samples from hospitalized patients with diarrhea in 76 hospitals in Switzerland on 2 days, 1 in winter and 1 in summer, in 2015. EIA C. difficile detection rates were 6.4 cases/10,000 patient bed-days in winter and 5.7 cases/10,000 patient bed-days in summer. PCR detection rates were 11.4 cases/10,000 patient bed-days in winter and 7.1 cases/10,000 patient bed-days in summer. We found PCR used alone increased reported C. difficile prevalence rates by <= 80% compared with a 2-stage EIA-based algorithm.

• All authors: Widmer, A.F.; Frei, R.; Kuijper, E.J.; Wilcox, M.H.; Schindler, R.; Spaniol, V.; Goldenberger, D.; Egli, A.; Tschudin-Sutter, S.
• Date: 2020-10-01
• Journal: Emerging Infectious Diseases
• Volume: 26
• Issue: 10
• Pages: 2370 - 2377
• DOI: doi:10.3201/eid2610.190804
• Link: https://wwwnc.cdc.gov/eid/article/26/10/19-0804_article